Nasdaq Approves Listing of Canary’s Staked Injective ETF

The proposed INJC fund would stake at least 90% of its INJ holdings and charge a 1.10% annual sponsor fee.
This is the summary The Defiant publishes in its feed. The full article lives on their site.